Patient (pt)-reported function and symptoms in APHINITY: A randomized comparison of chemotherapy (C) + trastuzumab (H) + placebo (Pla) versus C + H + pertuzumab (P) as adjuvant therapy in pts with HER2-positive early breast cancer (EBC) Meeting Abstract
| Authors: | Baselga, J.; Petersen, J. A.; Clark, E.; Barton, C.; Restuccia, E.; Procter, M. J.; Sonnenblick, A.; Fumagalli, D.; Parlier, D.; Arahmani, A.; Viale, G.; Reaby, L. L.; Frank, E.; Gelber, R. D.; Piccart-Gebhart, M. J.; Bines, J.; von Minckwitz, G.; Gasper, S. M. |
| Abstract Title: | Patient (pt)-reported function and symptoms in APHINITY: A randomized comparison of chemotherapy (C) + trastuzumab (H) + placebo (Pla) versus C + H + pertuzumab (P) as adjuvant therapy in pts with HER2-positive early breast cancer (EBC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 14s |
| Language: | English |
| ACCESSION: | WOS:000442916000033 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.521 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 521 -- Source: Wos |
